Introduction
According to World Health Organization (WHO) estimates, gonorrhoea is one of the most prevalent bacterial sexually transmitted infections (STI). [1] It is a major public health concern globally causing substantial morbidity and economic burden. [2] Over the last decade, Neisseria gonorrhoeae has developed resistance against antimicrobial agents such as penicillin, tetracycline and quinolones in several countries including India. [3] 
Materials and Methods

Study population
This study was carried out in the Department of Microbiology in conjunction with Department of Dermatology and STD of a tertiary care hospital of North India. The study population comprised males with urethritis, females with endocervicitis attending STI clinic of the hospital. All patients were included in the study after taking informed consent.
Specimen processing
The urethral/endocervical samples were inoculated immediately after collection onto Modifi ed Thayer Martin medium (MTM) and the inoculated plates were transported to the laboratory in a candle jar for further incubation in 3-7% CO 2 (candle jar) at 36°C ± 1°C for 48 hours. The colonies suspected to be N. gonorrhoeae were presumptively identifi ed by Gram stain, oxidase test and superoxol test. Confi rmation of identity was based on rapid carbohydrate utilisation test (RCUT). Gonococcal isolates were stored at −70°C in glycerol broths. [8] Antimicrobial susceptibility testing All isolates were examined for susceptibility to penicillin (10 IU), ciprofl oxacin (5 μg), tetracycline (30 μg), ceftriaxone (30 μg), cefi xime (5 μg), azithromycin (15 μg) and spectinomycin (100 μg) by disk diffusion method as per CLSI guidelines. [9] ß-lactamase production is determined by chromogenic cephalosporin test. In addition minimum inhibitory concentration (MIC) for ceftriaxone was determined by E-test method [ Figure 1 ]. [9] N. gonorrhoeae ATCC 49226 strain and WHO reference strains A, C, E, G, J, K-Q were used as controls for disc diffusion and MIC testing. This centre has been participating in Gonococcal Antimicrobial Surveillance Program (GASP) organised by WHO-SEAR regional reference laboratory.
Data were expressed as percentages. The differences in percentages were statistically compared, tested for signifi cance by using χ 2 test and P values were determined.
Results
The number of gonococcal isolates studied were 50 (48 males and 2 females) in 1995-96, 60 (52 males, 4 females and 4 sexual contacts) in 2004-05, and 25 (25 males) during 2011-2013. [10, 11] Although N. gonorrhoeae isolated from sexual contacts had the same antimicrobial susceptibility profi le they are included in analysis of results. A signifi cant increase in PPNG has been observed over the years. The percentage of PPNG increased from 8% in 1995-96 to 20% in 2004-05 (χ 2 = 2.268, P = 0.1321) and 88% in 2011-2013 (χ 2 = 31.226, P < 0.0001). [10, 11] QRNG showed a signifi cant increase from 12% in 1995-96 to 98.3% in 2004-05 (χ 2 = 80.557, P < 0.0001), while 84% isolates were found to be QRNG by 2011-2013 (χ 2 = 4.215, P = 0.0401). Percentage of TRNG was found to be 28% in 1995-96, 18.3% in 2004-05 (χ 2 = 0.953, P = 0.329) and 12% in 2011-2013 (χ 2 = 0.157, P = 0.6918). Although the percentage TRNG has decreased over the years, chromosomally mediated resistance to tetracycline has increased. [10, 11] All strains of N. gonorrhoeae isolated over the years from our institute were found to be sensitive to both azithromycin and spectinomycin. In January 2013, we detected our fi rst gonococcal isolate with decreased susceptibility to third-generation cephalosporins; Ceftriaxone, Cefi xime and Cefpodoxime by disk diffusion method, which was further confi rmed by MIC testing (MIC for ceftriaxone = 0.19 μg/ml) using WHO K as control strain. The MIC90 of ceftriaxone for N. gonorrhoeae isolates has also increased from 0.016 μg/ ml in 2004-05 to 0.023 μg/ml in 2011-13 [11] [ Figure 2 ].
Discussion
The number of cases of gonorrhoea and hence gonococcal isolates has declined in our hospital over the years. It may be either due to actual decreasing incidence of gonorrhoea over the years or due to the fact that gradually Surveillance of antimicrobial resistance is required to monitor trends in established types of resistance and promptly identify new types of resistance. Data from this centre have highlighted an alarming increase in the percentage of PPNG and QRNG strains over the years. [10, 11] Other studies from Nagpur (0%), Hyderabad (41.9%) and Kolkata (52.6%) have reported a lower percentage of PPNG, fi ndings similar to our study were reported from another WHO SEAR country, Thailand in 2013. [4] Bhutan and Thailand have also reported a signifi cant increase in QRNG strains over the years similar to our study. [4] In our study the percentage of TRNG has decreased over the years with 12% TRNG during 2011-13. Ray et al., reported a higher percentage of TRNG strains from Hyderabad (45.6%) and Nagpur (33.8%) while, a similar percentage was reported from Delhi (7.4-10%). [12] During our study we found one N. gonorrhoeae isolate with decreased susceptibility to all the third generation cephalosporins. In November 2013, Bala et al., reported 0.1%-84.2% N. gonorrhoeae isolates with decreased susceptibility to third generation cephalosporin in the WHO SEAR including India. [4] Treatment failure to cefi xime has been reported from several countries like Japan, France, Canada, Austria and Norway. [5, 6, 13] Recently ceftriaxone resistant isolates have been identifi ed in Japan (2009), France (2010) and Spain (2011). [5, 7, 14] All the gonococcal isolates in our study were sensitive to azithromycin and spectinomycin. Bala et al., reported <5% gonococcal isolates resistant to azithromycin from WHO SEAR. [4] Spectinomycin-resistant strains have recently been reported from India (New Delhi and Kolkata) and Bhutan. [4, 15] A small number of spectinomycin-resistant strains have been reported from China and Vietnam also. [16] Spectinomycin is not easily available in India and this may explain the retention of effi cacy of this antimicrobial.
The very high rate of antimicrobial resistance among N. gonorrhoeae isolates may be an indicator of the overuse and misuse of antimicrobials due to over-the-counter availability, self-medication or prescription by unqualifi ed practitioners. [17] Since the study was conducted in a tertiary care hospital with a large turnaround of OPD attendees including patients referred from various centres, there is a possibility that patients present to our centre after having already been treated elsewhere thus magnifying the problem of drug resistance. Also, as the number of isolates in the present study was small, a study with larger number of patients would be required to give a better evidence of the problem of drug resistant N. gonorrhoeae in the community.
Increase in N. gonorrhoeae isolates which are resistant to multiple antimicrobial agents is now a serious problem. [2] Emergence of N. gonorrhoeae isolates with decreased susceptibility/resistance to ceftriaxone, as a consequence of excess utilisation of oral third-generation cephalosporins for other infectious conditions, may pose a serious threat in the management of gonorrhoea in countries like India. Thus, continuous monitoring of antimicrobial susceptibility of all gonococcal strains circulating in a community should be performed to prevent treatment failures and further spread of resistant strains. At the same time, a search for new effective agents should be initiated as a solution to the problem. Progress towards a vaccine is urgently needed.
